Christopher M. Henstridge

4.2k total citations
37 papers, 2.4k citations indexed

About

Christopher M. Henstridge is a scholar working on Cellular and Molecular Neuroscience, Physiology and Pharmacology. According to data from OpenAlex, Christopher M. Henstridge has authored 37 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 14 papers in Physiology and 13 papers in Pharmacology. Recurrent topics in Christopher M. Henstridge's work include Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cannabis and Cannabinoid Research (11 papers). Christopher M. Henstridge is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cannabis and Cannabinoid Research (11 papers). Christopher M. Henstridge collaborates with scholars based in United Kingdom, United States and Hungary. Christopher M. Henstridge's co-authors include Tara L. Spires‐Jones, Andrew J. Irving, Bradley T. Hyman, Maria Waldhoer, Nariman Balenga, Eleanor K. Pickett, Rosa Chiara Paolicelli, Makis Tzioras, Ruth A. Ross and Julia Kargl and has published in prestigious journals such as Nature Communications, Neuron and Journal of Neuroscience.

In The Last Decade

Christopher M. Henstridge

37 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Henstridge United Kingdom 24 915 868 817 658 429 37 2.4k
Francesca Boscia Italy 35 1.5k 1.6× 569 0.7× 1.5k 1.8× 426 0.6× 421 1.0× 80 3.0k
Fulvio Florenzano Italy 32 820 0.9× 555 0.6× 1.0k 1.2× 898 1.4× 389 0.9× 73 2.9k
Anke Witting Germany 22 928 1.0× 1.3k 1.5× 565 0.7× 437 0.7× 557 1.3× 25 2.5k
Tariq Ahmed Belgium 26 947 1.0× 276 0.3× 902 1.1× 863 1.3× 350 0.8× 57 2.3k
Ana Ricobaraza Spain 20 588 0.6× 498 0.6× 1.1k 1.3× 618 0.9× 217 0.5× 35 2.2k
Bhavya Voleti United States 14 883 1.0× 530 0.6× 604 0.7× 282 0.4× 232 0.5× 16 2.3k
Holly D. Oakley United States 8 933 1.0× 673 0.8× 1.2k 1.4× 2.5k 3.9× 924 2.2× 10 3.6k
Iddo Magen Israel 24 617 0.7× 334 0.4× 598 0.7× 402 0.6× 215 0.5× 38 2.0k
Agostino Palmeri Italy 30 1.1k 1.2× 994 1.1× 1.4k 1.7× 2.0k 3.1× 694 1.6× 66 3.6k
Giampiero Leanza Italy 26 1.4k 1.5× 369 0.4× 905 1.1× 374 0.6× 317 0.7× 72 2.5k

Countries citing papers authored by Christopher M. Henstridge

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Henstridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Henstridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Henstridge more than expected).

Fields of papers citing papers by Christopher M. Henstridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Henstridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Henstridge. The network helps show where Christopher M. Henstridge may publish in the future.

Co-authorship network of co-authors of Christopher M. Henstridge

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Henstridge. A scholar is included among the top collaborators of Christopher M. Henstridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Henstridge. Christopher M. Henstridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, C. Roland, et al.. (2024). Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS. Open Biology. 14(10). 240073–240073. 1 indexed citations
2.
Henstridge, Christopher M., et al.. (2023). Bringing synapses into focus: Recent advances in synaptic imaging and mass-spectrometry for studying synaptopathy. Frontiers in Synaptic Neuroscience. 15. 1130198–1130198. 7 indexed citations
3.
László, Zsófia I., Douglas J. Lamont, Johannes Lehmann, et al.. (2023). Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. Acta Neuropathologica. 146(3). 451–475. 8 indexed citations
4.
Henstridge, Christopher M., et al.. (2022). Array tomography: 15 years of synaptic analysis. PubMed. 6(3). NS20220013–NS20220013. 4 indexed citations
5.
László, Zsófia I., Rachel Kline, Samantha L. Eaton, et al.. (2022). Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex. Acta Neuropathologica Communications. 10(1). 156–156. 24 indexed citations
6.
Erolin, Caroline, et al.. (2022). The transparent minds: methods of creation of 3D digital models from patient specific data. Journal of Visual Communication in Medicine. 45(2). 83–97. 2 indexed citations
7.
8.
Perkins, Emma, Karen Burr, Poulomi Banerjee, et al.. (2021). Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction. Molecular Neurodegeneration. 16(1). 13–13. 35 indexed citations
9.
Henstridge, Christopher M., Bradley T. Hyman, & Tara L. Spires‐Jones. (2019). Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis. Nature reviews. Neuroscience. 20(2). 94–108. 238 indexed citations
10.
Hurtado, Maica Llavero, Rosemary J. Jackson, Samantha L. Eaton, et al.. (2019). Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype. Acta Neuropathologica Communications. 7(1). 214–214. 59 indexed citations
11.
White, Matthew A., Ziqiang Lin, Eugene Kim, et al.. (2019). Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathologica Communications. 7(1). 166–166. 65 indexed citations
12.
Pickett, Eleanor K., Jamie Rose, Chris-Anne McKenzie, et al.. (2018). Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease. Acta Neuropathologica. 136(5). 747–757. 98 indexed citations
13.
Henstridge, Christopher M., Emily Carroll, Makis Tzioras, et al.. (2017). Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathologica. 135(2). 213–226. 85 indexed citations
14.
Jung, Kwang‐Mook, Marja D. Sepers, Christopher M. Henstridge, et al.. (2012). Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nature Communications. 3(1). 1080–1080. 207 indexed citations
15.
Henstridge, Christopher M.. (2012). Off-Target Cannabinoid Effects Mediated by GPR55. Pharmacology. 89(3-4). 179–187. 51 indexed citations
16.
Balenga, Nariman, Christopher M. Henstridge, Julia Kargl, & Maria Waldhoer. (2011). Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor 55. Advances in pharmacology. 62. 251–277. 27 indexed citations
17.
Henstridge, Christopher M., Nariman Balenga, R Schröder, et al.. (2010). GPR55 ligands promote receptor coupling to multiple signalling pathways. British Journal of Pharmacology. 160(3). 604–614. 171 indexed citations
18.
Ross, RA, et al.. (2010). Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid‐like’ receptors in small arteries. British Journal of Pharmacology. 159(4). 787–796. 71 indexed citations
19.
McDonald, Neil, Christopher M. Henstridge, Christopher N. Connolly, & Andrew J. Irving. (2007). Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging. Molecular and Cellular Neuroscience. 35(2). 237–248. 30 indexed citations
20.
McDonald, Neil, Christopher M. Henstridge, Christopher N. Connolly, & Andrew J. Irving. (2006). An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor. Molecular Pharmacology. 71(4). 976–984. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Boscia Breakdown of academic impact, for papers by Fulvio Florenzano Breakdown of academic impact, for papers by Anke Witting Breakdown of academic impact, for papers by Tariq Ahmed Breakdown of academic impact, for papers by Ana Ricobaraza Breakdown of academic impact, for papers by Bhavya Voleti Breakdown of academic impact, for papers by Holly D. Oakley Breakdown of academic impact, for papers by Iddo Magen Breakdown of academic impact, for papers by Agostino Palmeri Breakdown of academic impact, for papers by Giampiero Leanza
Rankless by CCL
2026